Peptide Pharmacology Ongoing preclinical studies examine receptor interactions, peptide distribution, and molecular mechanisms to better understand the biological characteristics of these investigational compounds
Injectable dose: 1-2mg daily subcutaneous Optional topical: 0.5-2% solution to problem areas Timing: Any time of day, food intake does not affect absorption Cycle length: 8-12 weeks on, 4-6 weeks off When to start: After 15-20lb weight loss or preemptively TB-500: Systemic Recovery and Inflammation Thymosin Beta-4 fragment, commonly known as TB-500, provides whole-body recovery support through mechanisms distinct from other healing peptides
Balances gene expression, speeding up cellular repair
F., Peng, Y., Hou, W
In wound-healing studies, thymosin beta-4 has been linked to: enhanced cell migration angiogenesis re-epithelialisation modulation of inflammation support for tissue remodelling This is why TB-500 is often discussed in recovery circles as a peptide that may support the environment in which healing happens rather than acting as a simple muscle builder or direct stimulant
The problem of patients being told that they will not be receiving their injections due to the risk of spreading the Covid-19 virus has been the sole topic in telephone calls and emails to the society in the past two weeks